Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Austin Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$9,237,127

1,740 payments

Through program year 2025, Austin Clinical Research LLC is reported as receiving $9,237,127 in research payments, across 1,740 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $2,649,389 603
2024 Research $2,004,360 424
2023 Research $2,011,001 378
2022 Research $2,331,853 326
2021 Research $240,524 9

Breakdown

Who paid Research payments · program years 2021–2025
  1. Genentech, Inc. $5,947,196 1,146 payments
  2. Roche TCRC, Inc. $1,875,478 275 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $575,005 65 payments
  4. Kyowa Kirin, Inc. $245,532 112 payments
  5. Janssen Research & Development, LLC $159,635 59 payments
  6. EyePoint Pharmaceuticals US, Inc. $123,964 3 payments
  7. Boehringer Ingelheim International GmbH $120,348 3 payments
  8. Apellis Pharmaceuticals, Inc. $58,203 34 payments
  9. Ocular Therapeutix, Inc. $48,227 15 payments
  10. Hoffmann-La Roche Limited $47,970 11 payments
Studies the money was for Research payments · program years 2021–2025
  1. Port Delivery System of Ranibizumab Extension Study $1,062,680 87 payments
  2. Iamd Observational Study $1,039,660 426 payments
  3. Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $835,489 42 payments
  4. Mad to Assess the Safety Tolerability and PK PD in Namd Patients $675,499 74 payments
  5. Entry Into Human of Ro7497372 in Participants With Diabetic MacUlar Edema $614,552 53 payments
  6. A Phase 1 Sad MD in Diabetic MacUlar Edema $581,332 139 payments
  7. Phase 2 Study to Investigate Ro7200220 in Diabetic MacUlar Edema $434,676 115 payments
  8. Faricimab for Under Represented Patients With Dme $343,267 121 payments
  9. Oral Treatment of NPDR $323,914 28 payments
  10. Ro7200394 for Namd $240,170 44 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record